Legal Representation
Attorney
Caroline H. Mead, Esq.
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 31, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 31, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 29, 2010 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 4, 2010 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 4, 2010 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 27, 2010 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Mar 25, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 25, 2010 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 25, 2010 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 25, 2010 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 25, 2010 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 25, 2010 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 25, 2010 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 22, 2010 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 15, 2010 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 15, 2010 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 15, 2010 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 8, 2010 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 14, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 14, 2010 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Jan 5, 2010 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Dec 24, 2009 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 22, 2009 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cerebral and neurologic disorders, diseases and conditions; Pharmaceutical preparations for the treatment of the symptoms of Alzheimer's disease
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"XL"